Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of domestic vs imported ticagrelor and dose comparison of domestic ticagrelor in acute coronary syndrome
ChiCTR2000032736Phase 4Not yet recruiting
- Sponsor
- Tangshan Gongren Hospital
- Start
- Jan 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of ticagrelor in acute coronary syndrome (ACS) (4 arms), sponsored by Tangshan Gongren Hospital. Primary endpoint: Platelet aggregation rate. Planned start Jan 2020; status: not yet recruiting.
02
Drugs
ticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on ChiCTR2000032736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000032736.